Advocacy group urges orphan status for multidrug-resistant infections

03/8/2012 | Reuters

The Infectious Diseases Society of America is urging the FDA to grant orphan-disease status to drug-resistant bacterial infections, offering drugmakers marketing rights, tax credits and other incentives and paving the way for faster approval of drugs to combat the diseases.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC